UK-based Menopause startup Vira Health has raised £9.2m in funding led by Octopus Ventures to invest in product development and internationalization. The round was led by Octopus Ventures with participation from existing investors including LocalGlobe, MMC and Amino Collective and Optum Ventures. Last summer Vira Health raised £1.5M in seed funding.
Vira Health’s first product Stella, a menopause-focused digital therapeutics, launched last year. The new funds will be used to add new features like telehealth and pharmacy services. The goal is to deliver a complete care pathway for menopause treatment. The company also plans to expand to the U.S.
Vira Health Co-founder & CEO explains: “The Stella app offers women a highly personalized, completely private and always-on treatment option. It is designed for a diversity of companies wanting to expand their employee benefit schemes. Our focus is onboarding more employers to Stella this year.”
Her Co-founder Dr. Rebecca Love adds: “It is outrageous that we have not focused on menopause care more. Stella provides women the relief and support they need for symptoms such as sleep issues, incontinence, mood swings, hot flushes and many others, and helps set women up for better brain, bone, and heart health in later life.”
